Meet Us at the Asia–Pacific Vaccine and Immunotherapy Congress 2026 (APVIC 2026), 6–8 May 2026, Biopolis, Singapore

Conference: Asia–Pacific Vaccine and Immunotherapy Congress 2026 (APVIC 2026)
Date: 6–8 May 2026
Location: Matrix, Biopolis, Singapore

Join us in Singapore for the Asia–Pacific Vaccine and Immunotherapy Congress (APVIC) 2026!
This international congress brings together leading scientists, clinicians, researchers, and industry experts working at the forefront of vaccinology, immunology, and immunotherapy.

APVIC 2026 will serve as a dynamic platform for knowledge exchange and collaboration, covering cutting-edge research in vaccine development, immune responses, infectious diseases, cancer immunotherapy, translational medicine, and public health strategies. The conference aims to foster interdisciplinary dialogue and strengthen partnerships across academia, healthcare, and industry in the Asia–Pacific region and beyond.

Don’t miss this opportunity to connect with peers, share insights, and contribute to the advancement of vaccine and immunotherapy research. Register now and be part of this vibrant scientific community.

The following journals will represent MDPI at the conference:

• Vaccines;
• Viruses;
• Antibodies;
• Antioxidants;
• Biologics;
• COVID;
• Immuno;
• IJERPH;
• JPM;
• Proteomes.

If you are planning to attend APVIC 2026, feel free to reach out and start a conversation with us. Our team looks forward to meeting you in person and will be happy to discuss publishing opportunities or answer any questions that you may have.

For more information about the congress, please visit https://www.apvic.org/.